FDA shuts down Ashanti factory, orders immediate recall of Arcan Bitters over dangerous drug contamination

Ghana's Food and Drugs Authority (FDA) has taken decisive action against a major public health threat, ordering the immediate recall of Arcan Bitters and shutting down the Parkoso manufacturing facility in Asokore Mampong Municipality, Ashanti Region, after laboratory testing revealed the product has been laced with Sildenafil Citrate without consumer knowledge.

The recall directive, issued on 2 September 2026, gives manufacturer Unni Associates Company Limited just 14 days to remove all stock from the market. The discovery represents a serious breach of food and drug safety standards, with the FDA warning that consumers face potentially life-threatening health consequences from unknowingly ingesting the prescription medication.

Health risks and dangerous interactions

Sildenafil Citrate, the active ingredient in erectile dysfunction medications, is a prescription-only substance that should never appear in food or beverage products. The FDA has outlined several critical health dangers associated with consuming the drug without medical supervision or knowledge.

The primary concern is that Sildenafil can interact dangerously with other medicines consumers may be taking, causing a sudden and severe drop in blood pressure. This sudden hypotension can trigger catastrophic cardiovascular events, including stroke or heart attack. Beyond these immediate acute risks, the FDA warns that prolonged exposure to undeclared Sildenafil may cause lasting damage, including vision loss and hearing impairment.

Consumers who may have purchased or consumed Arcan Bitters are urged to seek medical advice immediately if they experience any symptoms including chest pain, severe headache, vision changes, or fainting.

Why this matters for Ghana

This case highlights a troubling trend of product adulteration in Ghana's beverage market and underscores the FDA's critical role in protecting public health. The contamination of a popular alcoholic drink with an undeclared pharmaceutical substance represents a breach of trust and a violation of Ghanaian consumer protection laws.

Under the Public Health Act 2012 (Act 851), adulterating food products is a criminal offence, and the FDA has signalled its commitment to enforcement by threatening Unni Associates with further sanctions, including criminal prosecution, should the company fail to comply with the recall order. The agency will also oversee safe disposal of contaminated stock.

For ordinary Ghanaians, the message is clear: unregulated manufacturers pose genuine health risks. Consumers should purchase beverages only from authorised retailers and should be cautious of products from unfamiliar sources. The FDA has also called on the public to report any continued sale of Arcan Bitters to the nearest FDA office to ensure complete market removal.

FDA enforcement and public vigilance

The authority has advised retailers and distributors to comply immediately with the recall directive. The swift action demonstrates the FDA's operational capacity to identify and act on contaminated products, though critics may question how the adulteration went undetected until laboratory analysis revealed it.

Citizens are encouraged to remain vigilant and report any suspicious products or sellers attempting to continue selling recalled items. The FDA can be contacted through local offices nationwide to report non-compliance or unsafe products.